BIOMAT Database Logo BIOMAT Database Logo

Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans. 1988

T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Serum antibodies in some patients with systemic lupus erythematosus (SLE) were found to have specificity to idiotypes (Id) of 0-81 (human monoclonal anti-single-stranded DNA (ssDNA) antibody) but not to Id of NE-1 (human monoclonal anti-double-stranded DNA (dsDNA) antibody) or pooled human IgM. The interaction of the antibodies and 0-81 was blocked by the co-existence of free ssDNA. Some of SLE sera also showed preferential binding to Id determinants of NE-1, which included the antigen-binding sites of the dsDNA antibody. Some other SLE sera reacted with both Id of 0-81 and NE-13. Thus, there was heterogeneous population among human anti-Id autoantibodies to anti-DNA antibodies. The anti-Id activity was commonly detected in inactive SLE sera, and less frequently in normal controls, suggesting some regulatory role for anti-Id antibodies in the production of autoantibodies.

UI MeSH Term Description Entries
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
[Anti-idiotypic auto-antibodies of anti-DNA antibodies in disseminated lupus erythematosus].
October 1989, La Tunisie medicale,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Use of anti-idiotypic antibodies to explore genetic mechanisms of production of anti-DNA antibodies.
April 1986, Cellular immunology,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Molecular heterogeneity of auto-anti-idiotypic antibodies in MLR-lpr/lpr mice.
September 1991, European journal of immunology,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Naturally occurring anti-idiotypic antibodies reactive with anti-DNA antibodies in systemic lupus erythematosus.
January 1998, Lupus,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Anti-idiotypic antibodies to rubella virus.
January 1989, Archives of virology,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Identification of anti-idiotypic antibodies to anti-phosphotyrosine antibodies in human sera.
January 1993, Autoimmunity,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Anti-idiotypic antibodies to delineate epitope specificity of anti-amiloride antibodies.
September 1994, The American journal of physiology,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
[Anti-idiotypic antibodies vaccines].
January 1988, Harefuah,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Appraisal of anti-idiotypic antibodies in the treatment of solid tumors in humans.
July 1992, Surgery, gynecology & obstetrics,
T Muryoi, and T Sasaki, and N Harata, and O Takai, and E Tamate, and K Yoshinaga
Expression of anti-idiotypic clones against auto-anti-DNA antibodies in normal individuals.
February 1983, Cellular immunology,
Copied contents to your clipboard!